Advertisements



AbbVie announces Humira patent dispute resolution, terms not stated

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

AbbVie announces global resolution of HUMIRA patent disputes with Fresenius Kabi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 18th, 2018

AbbVie announces HUMIRA patent license with Mylan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

AbbVie stock ticks higher as Humira patent dispute with Novartis resolved

AbbVie Inc. s.....»»

Category: topSource: marketwatchOct 11th, 2018

AbbVie resolves HUMIRA U.S. patent litigation with Boehringer Ingelheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S.

Shares of AbbVie Inc. rose 1.3% in premarket trade Tuseday after .....»»

Category: topSource: marketwatchMay 14th, 2019

Immersion discloses Samsung patent litigation settlement, terms not stated

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2019

AbbVie Looks To Upadacitinib To Protect Itself From Humira Patent Loss

AbbVie Looks To Upadacitinib To Protect Itself From Humira Patent Loss.....»»

Category: topSource: seekingalphaApr 10th, 2018

Biogen Cracks the Case With AbbVie for Humira Biosimilar

Biogen (BIIB) and partner Samsung Bioepis resolve an ongoing patent row with AbbVie regarding Biogen's biosimilar version of AbbVie's arthritis dr.....»»

Category: smallbizSource: nytApr 6th, 2018

AbbVie Settles Patent Dispute with Biogen

Biogen's Imraldi is expected to be launched in Europe in OctoberRelated Stocks: ABBV, BIIB,.....»»

Category: dealsSource: nytApr 6th, 2018

iRobot announces favorable decision in patent dispute

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 26th, 2018

Apple, Samsung settle U.S. patent dispute

Apple Inc and Samsung Electronics Co Ltd on Wednesday settled a years’ long patent dispute, according to a filing the U.S. District Court for the Northern District of California. The terms of the settlement were not disclosed in the court filing......»»

Category: topSource: moneycentralJun 27th, 2018

The Apple-Samsung "thermonuclear war" over Android is over, but at least we got these iPhone prototype photos out of the battle (AAPL)

Court filing Apple and Samsung settled a seven-year patent dispute earlier this week. The terms of the settlement aren't known.   For most people and Apple fans, there are no easy takeaways from the end of the case.&nbs.....»»

Category: topSource: businessinsiderJun 30th, 2018

HFF Inc. announces sale of Burnham Pointe in Chicago, terms not stated

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 18th, 2018

Abbvie settles Humira patent disputes with Novartis unit

Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira......»»

Category: topSource: reutersOct 11th, 2018

InnerWorkings announces multi-year technology contract, terms not stated

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 15th, 2018

AbbVie signs patent license agreements with Pfizer over Humira biosimilar

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 30th, 2018

Digital Ally"s stock rocked after disappointing ruling in Axon patent dispute

Shares of Digital Ally Inc. plummeted 45% toward a record low in premarket trading Tuesday, after the maker of video surveillance products for law enforcement and homeland security received an unfavorable ruling in its years-long patent dis.....»»

Category: topSource: marketwatch20 hr. 55 min. ago

BiondVax announces patent covering M-001 production processes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall22 hr. 40 min. ago

Arthur J. Gallagher acquires P2 Group, terms not stated

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2019

Peloton may be set back in battle against Flywheel ahead of IPO

Just hours after it announced it had  for an initial public offering, Peloton Interactive Inc. suffered a potential setback in its dispute with Flywheel Sports Inc. over possible patent... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkJun 12th, 2019